HUTCHMED (China) Limited is a publicly traded company trading on XASE, led by CEO Chig Fung Cheng.
No upcoming earnings scheduled for HUTCHMED (China) Limited
No earnings announcement scheduled
Past 9 earnings reports for HUTCHMED (China) Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | FY 2025 | $2.62Est: $1.43 | +83.2% | $548.5MEst: $591.4M | -7.3% | — |
| Aug 7, 2025 | H1 2025 | $2.61 | — | $277.7M | — | — |
| Mar 19, 2025 | FY 2024 | $0.22 | — | $630.2MEst: $437.0M | +44.2% | — |
| Jul 31, 2024 | H1 2024 | $0.15 | — | $305.7M | — | — |
| Feb 28, 2024 | FY 2023 | $0.58 | — | $838.0M | — | — |
| Jul 31, 2023 | H1 2023 | $0.97 | — | $532.9M | — | — |
| Feb 28, 2023 | FY 2022 | -$2.13 | — | $426.4M | — | — |
| Aug 1, 2022 | H1 2022 | -$0.96 | — | $202.0M | — | — |
| Mar 3, 2022 | FY 2021 | -$0.25 | — | $356.1M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.